Journal
INORGANIC CHEMISTRY
Volume 53, Issue 19, Pages 10030-10032Publisher
AMER CHEMICAL SOC
DOI: 10.1021/ic5017164
Keywords
-
Categories
Funding
- American Cancer Society [RSG-13-079-01-CDD]
- University of Kentucky for a Research Challenge Trust Fund Fellowship
Ask authors/readers for more resources
Two novel strained ruthenium(II) polypyridyl complexes containing a 2,3-dihydro-1,4-dioxino[2,3-f]-1,10-phenanthroline (dop) ligand selectively ejected a methylated ligand when irradiated with >400 nm light. The best compound exhibited a 1880-fold increase in cytotoxicity in human cancer cells upon light-activation and was 19-fold more potent than the well-known chemotherapeutic, cisplatin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
